John Michael Kilpatrick

A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)

Varsha Gandhi, John Michael Kilpatrick, William Plunkett et al. · Blood · 2005 · 99 citations · Full text

Purine nucleoside phosphorylase inhibitor BCX-1777 (Immucillin-H)—a novel potent and orally active immunosuppressive agent

Shanta Bantia, Patrick J. Miller, Cynthia Parker et al. · International Immunopharmacology · 2001 · 88 citations

Active Immunosuppressive Agent, Medicine, Immunosuppressive Therapy +7

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)

Nadezhda E. Yun, Nathaniel S. Linde, Michele A. Zacks et al. · Virology · 2008 · 70 citations · Full text

Vaccination, Viral Pathogenesis, Immunology +6

The Arthus Reaction in Rodents: Species-Specific Requirement of Complement

Alexander J. Szalai, Stanley B. Digerness, Alok Agrawal et al. · The Journal of Immunology · 2000 · 57 citations

Phase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia

Kumudha Balakrishnan, Dushyant Verma, Susan O’Brien et al. · Blood · 2010 · 43 citations · Full text